"Practical guide" to urine drug screening clarified

Mayo Clinic Proceedings

Volumn 83, Issue 7, 2008, Pages 848-849

  Reisfield, Gary M ^a   Bertholf, Roger L ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; CANNABINOID; COCAINE; METHAMPHETAMINE; OPIATE;

DRUG ABUSE; DRUG SCREENING; LETTER; PRACTICE GUIDELINE; URINALYSIS;

EID: 46749101659     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/83.7.848     Document Type: Letter

References (8)

1. Moeller KE, Lee KC, Kissack JC. Urine drug screening: practical guide for clinicians. Mayo Clin Proc. 2008;83(1):66-76.
2. Reisfield GM, Bertholf R, Barkin RL, Webb F, Wilson G. Urine drug test interpretation: what do physicians know? J Opioid Manag. 2007;3(2):80-86.
3. Reisfield GM, Webb FJ, Bertholf RL, Sloan PA, Wilson GR. Family physicians' proficiency in urine drug test interpretation. J Opioid Manag. 2007;3(6):333-337.
4. Levy S, Harris SK, Sherritt L, Angulo M, Knight JR. Drug testing of adolescents in general medical clinics, in school and at home: physician attitudes and practices. J Adolesc Health. 2006;38(4):336-342.
5. Millgate AG, Pogson BJ, Wilson IW, et al. Analgesia: morphine-pathway block in top1 poppies. Nature. 2004;431(7007):413-414.
6. Swotinsky RB, Smith DR. The Medical Review Officer's Manual. 3rd ed. Beverly Farms, MA: OEM Press; 2006.
7. Shults TF. Medical Review Officer Handbook. 8th ed. Durham, NC: Quadrangle Research; 2005.
8. 21 CFR 1308: clarification of listing of " tetrahydrocannabilols" in schedule I and exemption from control of certain industrial products and materials derived from the cannabis plant: final rules. Fed Regist. 2003;68(55):14114-14126.